Paper22017172
Antioxidant poly(lactic-co-glycolic) acid nanoparticles made with α-tocopherol-ascorbic acid surfactant.
Astete CE and 4 others. ACS Nano, 2011. Cited by 36 papers, by iCite.
Cite this record
ConductScience Library. Antioxidant poly(lactic-co-glycolic) acid nanoparticles made with α-tocopherol-ascorbic acid surfactant. Papers, record 22017172. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/22017172
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Antioxidant poly(lactic-co-glycolic) acid nanoparticles made with α-tocopherol-ascorbic acid surfactant.
- PubMed
Topics15
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Antioxidants | Major topic |
| Cell Membrane | Major topic |
| Lactic Acid | Major topic |
| Nanocapsules | Major topic |
| Polyglycolic Acid | Major topic |
| Surface-Active Agents | Major topic |
| alpha-Tocopherol | Major topic |
| Ascorbic Acid | |
| Diffusion | |
| Hep G2 Cells | |
| Humans | |
| Materials Testing | |
| Particle Size | |
| Polylactic Acid-Polyglycolic Acid Copolymer | |
| Surface Properties |
Source PubMed
Cited by9
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 36 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 40766767 | Synthetic and semi-synthetic antioxidants in medicine and food industry: a review. | Front Pharmacol | 2025 | https://conductscience.org/library/papers/40766767 | PubMed |
| 36910956 | Melamine Barbiturate as a Light-Induced Nanostructured Supramolecular Material for a Bioinspired Oxygen and Organic Radical Trap and Stabilization. | ACS Omega | 2023 | https://conductscience.org/library/papers/36910956 | PubMed |
| 34850306 | Modulatory effect of dietary copper nanoparticles and vitamin C supplementations on growth performance, hematological and immune parameters, oxidative status, histology, and disease resistance against Yersinia ruckeri in rainbow trout (Oncorhynchus mykiss). | Fish Physiol Biochem | 2022 | https://conductscience.org/library/papers/34850306 | PubMed |
| 33815664 | The Role of Nanomaterials in Stroke Treatment: Targeting Oxidative Stress. | Oxid Med Cell Longev | 2021 | https://conductscience.org/library/papers/33815664 | PubMed |
| 31336591 | Vitamin E-Loaded PLA- and PLGA-Based Core-Shell Nanoparticles: Synthesis, Structure Optimization and Controlled Drug Release. | Pharmaceutics | 2019 | https://conductscience.org/library/papers/31336591 | PubMed |
| 29849910 | Oxidative Stress in the Muscles of the Fish Nile Tilapia Caused by Zinc Oxide Nanoparticles and Its Modulation by Vitamins C and E. | Oxid Med Cell Longev | 2018 | https://conductscience.org/library/papers/29849910 | PubMed |
| 28783305 | Core-Cross-Linked Nanoparticles Reduce Neuroinflammation and Improve Outcome in a Mouse Model of Traumatic Brain Injury. | ACS Nano | 2017 | https://conductscience.org/library/papers/28783305 | PubMed |
| 24782361 | Linking an α-tocopherol derivative to cobalt(0) nanomagnets: magnetically responsive antioxidants with superior radical trapping activity and reduced cytotoxicity. | Chemistry | 2014 | https://conductscience.org/library/papers/24782361 | PubMed |
| 24392694 | Nanocarriers for vascular delivery of anti-inflammatory agents. | Annu Rev Pharmacol Toxicol | 2014 | https://conductscience.org/library/papers/24392694 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/22017172
GET https://conductscience.org/api/papers/v1/22017172/authors